Company / Shareholders' Equity
BIOMERICA INC Shareholders' Equity History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$4.1M
FY2025
5-year range
$4.1M / $11.7M
FY2021-FY2025
Trend
-37.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Shareholders' Equity has fluctuated over the past 10 years, ranging from $4M in FY2019 to $14M in FY2020.
Based on SEC 10-K filings.
$4M in FY2025 with a 5-year CAGR of -22.0%.
Declined from $12M to $4M over the past 2 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -21.0%
- 5-Year CAGR
- -22.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -22.0%, indicating a declining trend.
- In FY2025, shareholders' equity decreased 37.7% year-over-year.
- Peak shareholders' equity was recorded in FY2020.
- Lowest shareholders' equity in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -6.26 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.1M | -37.7% |
| FY2024 | $6.6M | -43.8% |
| FY2023 | $11.7M | +40.8% |
| FY2022 | $8.3M | -9.8% |
| FY2021 | $9.2M | -35.1% |
| FY2020 | $14.2M | +257.0% |
| FY2019 | $4.0M | -8.0% |
| FY2018 | $4.3M | -3.6% |
| FY2017 | $4.5M | -14.0% |
| FY2016 | $5.2M | -6.8% |
As of FY2025 · SEC Form 10-K · Last checked Jun 22, 2026